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Abstract
BIOCOS, the project aimed at studying BIOlogical systems in their COSmos, has obtained a great
deal of expertise in the fields of blood pressure (BP) and heart rate (HR) monitoring and of marker
rhythmometry for the purposes of screening, diagnosis, treatment, and prognosis. Prolonging the
monitoring reduces the uncertainty in the estimation of circadian parameters; the current
recommendation of BIOCOS requires monitoring for at least 7 days. The BIOCOS approach consists
of a parametric and a non-parametric analysis of the data, in which the results from the individual
subject are being compared with gender- and age-specified reference values in health.
Chronobiological designs can offer important new information regarding the optimization of
treatment by timing its administration as a function of circadian and other rhythms.
New technological developments are needed to close the loop between the monitoring of blood
pressure and the administration of antihypertensive drugs.
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INTRODUCTION
There is a growing body of evidence suggesting that time structures in us and around us are
intricately interwoven. Most if not all components of variation found in biota are also found
in the environment, and vice versa (1). For instance, about daily changes are seen in almost
every biological variable under 24-hour synchronized conditions. It has also long been known
that the phase of circadian rhythms can be manipulated by changing the phase of the
environmental cycles (2). At least for the case of circadian rhythms, their genetic inheritance
has been demonstrated on a molecular basis (3,4), suggesting that the influence from the
environment has been acquired genetically during the course of evolution.
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The mapping of chronomes should benefit our understanding of human health and disease in
several ways. The study of human chronomes can serve the derivation of refined reference
values to better define health and to identify pre-disease, so that prophylactic interventions can
be instituted as early as possible, preferably before disease sets in (5–7). The focus is thus put
on pre-habilitation, in the hope that the need for rehabilitation will thereby be reduced (8–
10). The study of chronomes of other organisms such as bacteria (11–13) is also meritorious
so that actions can be taken to protect humans and other animals from possible infections, and
to apply any eradicating methods at the most opportune time so as to achieve highest efficacy
with least side effects. Finally, the study of time structures in the environment may help
safeguard the integrity of the environment while also gaining a better understanding of the
relations between biota and their environment (14,15).
BIOCOS, the project aimed at studying BIOlogical systems in their COSmos, has obtained a
great deal of expertise in the fields of blood pressure (BP) and heart rate (HR) monitoring and
of marker rhythmometry for the purposes of screening, diagnosis, treatment, and prognosis.
Information gained from this work suggests a close link between mental health and
cardiovascular health (16). Too often the argument is presented that a chronobiological
approach relying on longitudinal monitoring of vital signs and on a computer-assisted analysis
for an inferential statistically guided interpretation of the results is too complex and too
expensive and hence cannot be generally introduced to developing countries where a cost-
effective health care system is needed the most. In the following, these misconceptions are
dispelled and the case is made for cardiovascular health that chronobiology offers the most
promising approach to improving the quality of care at a reduced cost.
Cost benefit of longitudinal monitoring versus single samples
Several studies (17,18) comparing the classification of patients based on single office
measurements with that based on ambulatory monitoring for one to seven days suggest that
the incidence of misdiagnosis is around 40 %, in keeping with the 48% response to placebo in
the Australian Therapeutic Trial (19,20). A comparison of circadian characteristics from day
to day in records spanning at least two days further indicates the shortcomings of monitoring
limited to a single 24-hour span (21–23). Prolonging the monitoring from one to two days
reduces the uncertainty in the estimation of circadian parameters by about 35 % (24), whereas
further information on the biological week (25–28) requires monitoring for at least 7 days, the
current recommendation of BIOCOS for everybody at the outset (29). It is now widely accepted
that prognosis of target organ damage is by far superior when it is based on around-the-clock
monitoring than on single office measurements (30–32).
There can also be large day-to-day changes in the circadian characteristics of blood pressure
and heart rate in some people. The mistaken impression that the circadian variation in blood
pressure and heart rate is sufficiently stable to be approximated by a single 24-hour profile
stems in large part from the use of statistical methods on groups of subjects rather than focusing
on the individual patient. Correlation analyses applied to large groups of subjects with a wide
range of average values emphasize similarity. Statistical analyses focusing on individual
differences observed from one profile to another, however, yield information more likely to
help the patient in need of treatment (21). Several case reports document this point (7,33–36).
Continued monitoring is the most logical solution. Feasible today by telemetry for the lifetime
of laboratory animals, it still awaits industrial developments for application in human beings.
Longitudinal monitoring does not need to be costly. The high cost of ambulatory blood pressure
monitoring prevailing today stems in large part from the practice to limit the procedure to
special cases. Should the recommendation to screen every citizen be embraced, the cost of
monitors would drop drastically as was the case for many commodities (such as the ballpoint
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pen, the wristwatch, and the pocket calculator) when they became widely accessible. Serial
blood pressure and heart rate data can also be obtained affordably by self-measurements, as
already advocated by Janeway in 1904 (37). Self-measurements taken 5 to 8 times a day during
waking, preferably with at least occasional nightly readings (which could be taken by a family
member so as not to interrupt sleep), have been successful to help the treatment of patients
with malignant hypertension (38). Manual measurements have also been successful to separate
children with or without familial antecedents of high blood pressure and/or related
cardiovascular disease and to predict outcomes (38,39) by the assessment of the circadian
amplitude of blood pressure interpreted in the light of reference values derived specifically for
self-measurements (24).
Merit of a chronobiological assessment and interpretation of the data
Taking serial measurements a few times each day is important to greatly reduce the error
associated with single measurements. The assessment by cosinor (2,40) of the circadian
amplitude and acrophase in addition to the MESOR further reduces the error term since blood
pressure and heart rate are usually characterized by a circadian variation of large extent. Taking
only one or two measurements a day, always at awakening and/or at bedtime, may fail to reveal
abnormalities seen only at other times of the day, or abnormalities that apply only to the
variability in blood pressure or heart rate.
By enlarging the monitoring to the population at large, clinically healthy individuals can
provide the reference values needed to identify any abnormality that may occur within the
physiological range. In view of gender differences and of changes in circadian characteristics
as a function of age, reference values are best specified by gender and age, and, whenever
possible, also by ethnicity. Outcome studies could further refine the reference standards by
relying primarily on the data provided by low-risk subjects. Reference values are needed not
only for the MESOR and for the amplitude and acrophase of the 24-hour component and all
pertinent harmonic terms, but also for the interpretation of time-specified single values (7).
Whereas the presence of a prominent circadian rhythm in blood pressure is no longer contested,
this knowledge has not been applied to time-specify the reference values, so that the diagnosis
does not depend on the clock hour of the clinical examination, as was demonstrated both
theoretically (34) and clinically (41).
A double-barreled approach has been developed for the interpretation of blood pressure and
heart rate records. It consists of a parametric and a non-parametric analysis of the data, in which
the results from the individual subject are being compared with gender- and age-specified
reference values in health (7). The reference values for parameters have led to the identification
of new disease risk syndromes, such as CHAT (circadian hyper-amplitude-tension, a condition
characterized by a circadian amplitude exceeding the upper 95% prediction limit), BP-ecphasia
(a condition characterized by a deviant circadian acrophase of blood pressure), and DHRV
(decreased heart rate variability, defined as a below-threshold standard deviation of heart rate
measurements collected around the clock). Together with an excessive pulse pressure (above
60 mmHg), CHAT and DHRV can make the difference between <4% and 100% morbidity in
a 6-year prospective study (42).
Need for international relational databases linking patterns and treatment
modalities to outcomes
A systematic organization into databases of all records, preferably with regular follow-ups of
the subjects who provided the records, would be invaluable to build evidence-based archives
(43). Information could thus be gathered to determine systematically and rigorously optimal
chronotherapeutic regimens and to identify pre-disease conditions in a timely fashion, so that
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prophylactic interventions may be instituted. In addition to the data, outcomes and pertinent
clinical data could be added to the existing databases. Information from both prospective trials
and from retrospective analyses could add to the current knowledge. A treatment regimen found
to be superior in large clinical trials in reducing the incidence of strokes and other
cardiovascular events is shown in a cross-over chronobiological pilot study to decrease the
incidence of CHAT. As different treatment regimens can affect the circadian blood pressure
amplitude differently (44,45), some schedule may induce iatrogenic CHAT, which in turn may
increase the risk of stroke, whereas another schedule may have the opposite effect (46). A
change in morbidity/mortality could thus be associated with changes in blood pressure and/or
heart rate characteristics occurring naturally or intentionally induced by a given intervention.
An important distinction needs to be made between lessons learned from large clinical trials
and their application for the individual patient. Differences and trends uncovered in studies on
groups, even when each subject provides only one or a few measurements, cannot be similarly
assessed in medical practice when a decision needs to be made for treating the individual
patient. In order to be able to reach an informed decision for the given patient, serial rather
than single data should be collected. When time series are available, it becomes possible to
assess risk elevation or the response to treatment for that particular patient. Available
procedures include parameter tests (47) and cumulative control charts (33,35). The kjnd of
treatment, dosing, and timing then all become amenable to optimization for the given patient.
The point also needs to be made that timing should routinely be introduced as a major factor
in clinical trials. Without any added cost, or rather with considerable saving, chronobiological
designs can offer important new information regarding the optimization of treatment by timing
its administration as a function of circadian and other rhythms. ‘Larger’ is not necessarily better
when timing is ignored, as documented both theoretically (48) and clinically (49,50).
Spin-offs from organized archives of long-term records
Once databases are organized to include archives of longitudinal records from test pilots,
special analyses may also serve basic science. For instance, these analyses may further the
understanding of the influence of environmental factors near and far on human physiology and
pathology (1). Cases in point include the biological week (51,52), the half-year (53), the trans-
year (54,55), and circadecadal and circamultidecadal cycles (1,56), notably an about 10.5-year
cycle in mortality from myocardial infarctions in Minnesota (57). In particular, the recent
detection of an about 1.3-year change in blood pressure and heart rate resembling the about
1.3-year variation in the velocity of the solar wind illustrates the fact that organisms are
influenced by non-photic as well as photic effects from the sun (54,55). Problems related to
the recent increase in mortality from stroke (1,57–60) could also be more readily investigated,
also accounting for a putative about 50-year cycle.
New technological developments
Not so many years ago, patients with diabetes used single daily injections of slow-acting insulin
preparations aimed at covering 24 hours. Any adjustment in the daily dose relied on glucose
tests in urine. Today, programmable insulin pumps use fast-acting insulin and patients are
encouraged to test their glucose concentrations in blood samples several times a day to achieve
tighter control and thereby reduce their risk of complications. In a first attempt to closing the
loop, the new Paradigm 512 insulin pump from Medtronic/MiniMed has recently been
combined with the Paradigm Link blood glucose meter, the two devices communicating with
each other by means of radio waves to automatically adjust the dosage of insulin delivery
(61). In the case of blood pressure, 24-hour formulations of antihypertensive agents are still
prevalent today, with the tacit implication that the need for medication remains constant from
moment to moment and from one day to another. The technology needed to close the loop
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between the monitoring of blood pressure and the administration of antihypertensive drugs,
however, should not differ too much from the technology already in use for the treatment of
diabetes.
For a wider acceptance of the monitoring of blood pressure, new approaches may have to be
considered. One possibility is the use of minimally invasive devices relying on an implanted
sensor to measure blood pressure beat to beat. Another area of rapid development relates to
the use of electronic textiles (62). Shirts are being designed to monitor a patient’s vital signs
and alert a doctor by means of a wireless signal at the first sign of trouble. Medical textiles
incorporate current-carrying fibers into fabrics to power electronic sensors that can monitor
the wearer’s breathing, temperature and heart rate, and may soon be capable of monitoring also
oxygen and blood glucose concentrations. The clothing thus becomes the monitoring device,
whereas software controls the communications inside the on-fabric network and can send radio
signals using Bluetooth or any other IEEE 802.11 wireless standard to personal computers and
over the Internet (63). This technology offers diverse applications among which the prevention
of sudden infant death syndrome (SIDS) is already within reach.
Concluding remarks
Optimization in manufacturing and marketing relies on monitoring, analysis, and outcome
studies. Similar systems are in place for tracking infections, as we recently witnessed in the
case of SARS (64). But this is not yet the case for personal health, the most precious commodity
of all. It may be high time to remedy the situation, notably since all ingredients for doing so
are available, namely the monitoring devices, the analytical procedures, treatment modalities
and ways to optimizing their scheduling of administration, and also drug delivery devices
(65). Closing the loop has started for diseases such as diabetes (insulin pump linked to glucose
sensor) (61), for certain cardiovascular conditions (pacemaker-cardioverter-defibrillators), but
not yet for blood pressure disorders that place a patient at a higher risk of cardiovascular disease
before there is overt disease.
Blood pressure can be as variable as blood sugar. Rather than focusing on 24-hour formulations
(one size fits all), tighter control may perhaps be achieved using first a radically different
strategy relying on faster acting antihypertensives that can be titrated as needed not only in
response to blood pressure measurements recorded automatically and continuously but also in
anticipation of the usual daily, weekly, and even longer (e.g., circannual) patterns known to
characterize blood pressure, including an increase prior to awakening, in preparation of the
next day’s activities (66). Whereas this may not happen overnight, we should not wait until
tomorrow to use the technology that is available today. Education in chronobiology literacy at
all ages can go a long way at an affordable cost, a small investment with potential great reward
if by pre-habilitation the very high cost of after-the-fact care can be drastically curtailed, an
approach equally applicable in developed, developing, and, where it is particularly needed, in
underdeveloped countries.
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